In June 2016 details of payments from pharmaceutical companies to healthcare professionals will be published by the ABPI on a publicly accessible database.
87% of HCPs surveyed agree that payments from pharmaceutical companies to individually named healthcare professionals should be transparent
One third (32%) of those questioned feel it is unnecessary to declare payments from pharmaceutical companies to individually named HCPs